Gene · 407017
Papers3,057
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,057
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| Genetic alterations in juvenile cervical clear cell adenocarcinoma unrelated to human papillomavirus. | Front Med (Lausanne) | 2023 | 37654657 | PubTator, text mining | PubMed |
| Differentiation value of miR-26b for major depressive disorder, schizophrenia, generalized anxiety disorder. | Indian J Psychiatry | 2023 | 37645356 | PubTator, text mining | PubMed |
| MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosis. | BMC Psychiatry | 2023 | 37644489 | PubTator, text mining | PubMed |
| Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles. | Front Oncol | 2023 | 37637043 | PubTator, text mining | PubMed |
| Prenatal and Neonatal Bone Health: Updated Review on Early Identification of Newborns at High Risk for Osteopenia. | Nutrients | 2023 | 37630705 | PubTator, text mining | PubMed |
| Multiomic Investigations into Lung Health and Disease. | Microorganisms | 2023 | 37630676 | PubTator, text mining | PubMed |
| Type I Interferon Pathway-Related Hub Genes as a Potential Therapeutic Target for SARS-CoV-2 Omicron Variant-Induced Symptoms. | Microorganisms | 2023 | 37630661 | PubTator, text mining | PubMed |
| The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies. | Int J Mol Sci | 2023 | 37629078 | PubTator, text mining | PubMed |
| Understanding Breast-Cancer-Associated Fibroblasts and Their Epigenetic Activation to Unveil Novel Targets for Breast Cancer Therapy. | Cancers (Basel) | 2023 | 37627101 | PubTator, text mining | PubMed |
| LINC01094 accelerates the metastasis of hepatocellular carcinoma via the miR-26b-3p/MDM4 axis. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37605571 | PubTator, text mining | PubMed |
| MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. | Cancer Cell Int | 2023 | 37587481 | PubTator, text mining | PubMed |
| Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow. | Front Cardiovasc Med | 2023 | 37583586 | PubTator, text mining | PubMed |
| Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 37577299 | PubTator, text mining | PubMed |
| Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies. | J Clin Transl Hepatol | 2023 | 37577221 | PubTator, text mining | PubMed |
| From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer. | Cancers (Basel) | 2023 | 37568824 | PubTator, text mining | PubMed |
| Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice. | Cancers (Basel) | 2023 | 37568746 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications. | Cancers (Basel) | 2023 | 37568568 | PubTator, text mining | PubMed |
| Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. | J Clin Med | 2023 | 37568462 | PubTator, text mining | PubMed |
| RDRGSE: A Framework for Noncoding RNA-Drug Resistance Discovery by Incorporating Graph Skeleton Extraction and Attentional Feature Fusion. | ACS Omega | 2023 | 37546619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407017/papers?page=11